• Tailored Niosomes for Psoriasis: Pentoxifylline Study

  2026-09-16

  The reference study developed a dual-drug niosomal system that combines topical cyclosporine delivery with Pentoxifylline to improve local management of psoriasis while addressing limitations of systemic cyclosporine. Box-Behnken optimization, ex-vivo skin studies, and an imiquimod-induced mouse model showed enhanced skin retention and improved disease-associated histopathology and severity scores.

• Sisomicin Activity Against Clinical Bacterial Isolates

  2026-09-15

  Stewart and Bodey evaluated the in vitro activity of the new aminoglycoside sisomicin against a broad collection of clinical gram-negative and gram-positive isolates. The study showed strong activity against most tested organisms, while cross-resistance with gentamicin and tobramycin highlighted the importance of comparative susceptibility testing and amikacin as a potential alternative.

• Ziprasidone Augmentation in Anxious Depression

  2026-09-15

  This post-hoc moderator analysis examined whether baseline anxious depression changed the response to ziprasidone added to escitalopram. Ziprasidone augmentation improved depressive symptoms similarly in anxious and nonanxious depression, while the apparent anxiety benefit in highly anxious patients was not clinically meaningful.

• Pentoxifylline: A cAMP Assay Decision Framework

  2026-09-14

  Explore how Pentoxifylline, a non-specific phosphodiesterase inhibitor, can be evaluated through a cAMP-centered assay strategy. This article connects pathway modulation with cytokine, adhesion, and translational disease-model readouts.

• High-Content Screening of Schistosome Neoblasts

  2026-09-14

  The reference study developed a quantitative high-content platform that measures somatic neoblast proliferation in developmentally advanced Schistosoma mansoni liver schistosomula. Screening a 280-compound stem cell-focused collection identified compounds that disrupted parasite development and stem cell proliferation, offering a more informative route to anti-schistosomal lead discovery than morphology or motility alone.

• Annexin V-FITC/PI Apoptosis Assay Kit Guide

  2026-09-13

  The Annexin V-FITC/PI Apoptosis Assay Kit provides a two-parameter method for separating viable, early apoptotic, and membrane-compromised cell populations by flow cytometry or fluorescence microscopy. It is intended for controlled research workflows and should not be used as a stand-alone diagnostic test or as definitive proof of a specific cell-death mechanism.

• MitMAB for Organoid Endocytosis Workflows

  2026-09-12

  MitMAB gives researchers a focused chemical perturbation for testing dynamin-dependent vesicle scission during extracellular-vesicle uptake. This workflow translates polarized intestinal organoid findings into practical dose screens, imaging controls, and troubleshooting strategies for intracellular trafficking research.

• Azithromycin for Resistance and Infection Models

  2026-09-12

  Build stronger bacterial infection research workflows with Azithromycin by combining concentration-response testing, peptide-mediated resistance screens, and stability checks. This guide connects ribosome-level mechanism to practical assay design and carefully frames its reported use in trypanosomosis animal models.

• NVP-BGJ398 Phosphate: FGFR3 Research Guide

  2026-09-11

  NVP-BGJ398 phosphate is a selective pan-FGFR1–3 inhibitor that blocks receptor autophosphorylation and downstream signaling. Preclinical evidence supports its use in FGFR-driven cancer models and in SLC26A2-related chondrodysplasia research, but these findings do not establish clinical efficacy.

• DiscoveryProbe Stem Cell Compound Library Plus Workflow

  2026-09-11

  DiscoveryProbe™ Stem Cell Compound Library Plus turns broad pathway coverage into a practical workflow for stem cell differentiation, self-renewal, and mechanism-guided phenotypic screening. Its strongest advantage is the combination of high-content imaging, pathway-focused perturbations, and orthogonal validation that distinguishes genuine cell-state changes from nonspecific toxicity.

• Pentoxifylline Workflows for Inflammation Research

  2026-09-10

  Build reproducible Pentoxifylline assays for cytokine suppression, macrophage activation, and topical psoriasis models. A formulation-focused workflow shows how niosome delivery can shift the endpoint from systemic exposure toward controlled skin deposition.

• Pioglitazone for Reliable Cell Assays

  2026-09-10

  This scenario-driven guide explains how Pioglitazone, SKU B2117, can support reproducible PPARγ, viability, macrophage-polarization, and metabolic research workflows. It connects formulation, assay controls, published DSS-model evidence, and practical vendor-selection criteria without confusing receptor activation with cytotoxicity.

• Tetrahedral DNA Frameworks Improve Enzymatic Synthesis

  2026-09-09

  The reference study shows that tetrahedral DNA nanostructures can organize primers at a defined interface, improving enzyme accessibility, catalytic behavior, and oligonucleotide synthesis fidelity. Its application to DNA information storage demonstrates how nanoscale primer presentation may address deletion errors in enzymatic oligonucleotide synthesis.

• T0070907: A Practical PPARγ Antagonist Workflow

  2026-09-09

  T0070907 gives researchers a high-affinity chemical switch for testing PPARγ-dependent transcription, adipogenesis inhibition, macrophage signaling, and cell-cycle responses. This workflow connects receptor pharmacology with the RXRα/PPARγ/NEDD4 axis while emphasizing solvent control, pathway validation, and separation of receptor-specific effects from cytotoxicity.

• Ceftazidime: A Resistance-Aware Research Framework

  2026-09-08

  Ceftazidime is a third-generation cephalosporin whose activity can be interpreted more intelligently when antibiotic testing is integrated with resistance-gene localization and transfer assays. This guide translates the 2025 Guangdong CREC study into practical decisions for Gram-negative bacterial infection research, especially respiratory surveillance.

8028 records 1/536 page Next 12345 下5页 Last page